Faculty profile

Ivan Pasic

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Toronto

Ivan Pasic

Assistant Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
55 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

750

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.
British journal of haematology · 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.
JCO oncology practice · 2026
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation.
Transplantation and cellular therapy · 2026

All 71 publications

Latest funding

A type 1 hybrid effectiveness-implementation trial of a longitudinal multidimensional rehabilitation program for patients undergoing allogeneic blood and marrow transplantation (CaRE-4-alloBMT)
CIHR · 2024 · Co-investigator
$638,776

All 1 grants and awards

71 publications.

Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.

Desai N, Althobaiti M, Chen C, Al-Shaibani E, Moya TA, Novitzky-Basso I, Pasic I, Michelis FV, Kim DD, Kumar R, Mattsson J, Law AD, Viswabandya A

British journal of haematology20263 citations

DOI: 10.1111/bjh.70380 PMID: 41747740

Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

Desai N, Rodriguez-Rodriguez S, Chen C, Al-Shaibani E, Alfaro Moya T, Novitzky-Basso I, Pasic I, Michelis FV, Viswabandya A, Kim DDH, Kumar R, Mattsson J, Law AD

JCO oncology practice20261 citations

DOI: 10.1200/op-25-01308 PMID: 42372210

Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation.

Hall VG, Chiarello C, Remberger M, Kumar D, Pasic I, Kim DDH, Kumar R, Viswabandya A, Michelis FV, Law A, Gerbitz A, Humar S, Lam W, Novitzky-Basso I, Mattsson J

Transplantation and cellular therapy20261 citations

DOI: 10.1016/j.jtct.2025.10.028 PMID: 41167523

GVHD Prophylaxis With ATG and PTCy Versus PTCy-Based Regimens in Haploidentical Stem Cell Transplantation: A CTTC Study.

Garcia-Horton A, Salter B, Paulson K, Musto G, Ikuomola O, Bucher O, Seftel M, Truong TH, Hay KA, Prica A, Bhella S, Mattsson J, Pasic I

Transplantation and cellular therapy20261 citationsSenior author

DOI: 10.1016/j.jtct.2026.03.025 PMID: 41871755

Frailty as a Prognostic Factor in Younger Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Rodriguez-Rodriguez S, Salas MQ, Desai N, Al-Shaibani E, Novitzky-Basso I, Pasic I, Viswabandya A, Michelis FV, Mattsson J, Kim DDH, Kumar R, Moya TA

Transplantation and cellular therapy20261 citations

DOI: 10.1016/j.jtct.2026.01.026 PMID: 41571188

Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation

Fotios V. Michelis, Ivan Pasic, Eleftherios P. Diamandis

Current Opinion in Hematology2026

DOI: 10.1097/moh.0000000000000951 PMID: 42673525

Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation.

Chiarello C, Singhabahu S, Remberger M, Chen C, Moya TA, Al-Shaibani E, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J, Pasic I

Transplantation and cellular therapy2026Senior author

DOI: 10.1016/j.jtct.2025.10.002 PMID: 41062023

Ferritin as a Pre-Transplant Biomarker for Post-Transplant Outcomes in Allogeneic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide.

Rodriguez-Rodriguez S, Chiarello C, Desai N, Remberger M, Chen C, Al-Shaibani E, Alfaro Moya T, Law AD, Pasic I, Viswabandya A, Michelis FV, Kim DDH, Kumar R, Mattsson J, Novitzky-Basso I

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2026.03.015 PMID: 41839367

Prior Malignancy History and Risk of Second Malignancies After Allogeneic Hematopoietic Cell Transplantation.

Desai N, Al-Shaibani E, Alfaro-Moya T, Law AD, Lam W, Pasic I, Novitzky-Basso I, Viswabandya A, Kim DD, Kumar R, Lipton JH, Mattsson J, Michelis FV

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2026.05.018 PMID: 42142626

Clinical Impact of Human Herpesvirus 6B Reactivation on Engraftment and Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation.

Hosseini-Moghaddam SM, Johnstone RB, Mazzulli T, Remberger M, Pasic I, Mattsson J, Parveen F, Chen C, Husain S, Runyo F, Michelis FV

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2026.01.008 PMID: 41525945

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Ivan Pasic

Research

Latest papers

Latest funding

Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.

Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation.

GVHD Prophylaxis With ATG and PTCy Versus PTCy-Based Regimens in Haploidentical Stem Cell Transplantation: A CTTC Study.

Frailty as a Prognostic Factor in Younger Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation

Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation.

Ferritin as a Pre-Transplant Biomarker for Post-Transplant Outcomes in Allogeneic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide.

Prior Malignancy History and Risk of Second Malignancies After Allogeneic Hematopoietic Cell Transplantation.

Clinical Impact of Human Herpesvirus 6B Reactivation on Engraftment and Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation.

A type 1 hybrid effectiveness-implementation trial of a longitudinal multidimensional rehabilitation program for patients undergoing allogeneic blood and marrow transplantation (CaRE-4-alloBMT)

Frequent collaborators

Jonas Mattsson

Auro Viswabandya

Rajat Kumar

Wilson Lam

Igor Novitzky-Basso

Tommy Moya

Eshrak Al-Shaibani

Tommy Alfaro Moya

Dennis Kim

Kristjan Paulson

Eleftherios Diamandis

Shabbir Alibhai

Vathany Kulasingam

Deepali Kumar

Sasan Hosseini-Moghaddam

Sita Bhella

Mohamed Elemary

Tony Truong

Anca Prica

Tony Mazzulli

Seyed Hosseini-Moghaddam

Shahid Husain

Atul Humar

Victor Ferreira

Fotios Michelis

Imran Ahmad